| Literature DB >> 25955252 |
Shu-Jui Kuo1, Feng-Sheng Wang2, Ching-Jen Wang3, Jih-Yang Ko3, Sung-Hsiung Chen4, Ka-Kit Siu4.
Abstract
UNLABELLED: Total knee arthroplasty (TKA) inevitably perturbs the femoral medullary canal, which increases blood loss or morbidities associated with marrow embolization postoperatively. Computer navigation TKA reportedly minimizes medullary disturbance to alleviate perioperative blood loss. We performed a prospective comparative study, enrolling 87 patients with osteoarthritic knees from March 2011 to December 2011 in our hospital. The patients were separated into two groups, according to the surgeon they visited. Fifty-four patients underwent computer navigation TKAs and 33 had conventional TKAs. Levels of cell adhesion molecules (CAMs), including intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and platelet endothelial cellular adhesion molecule-1 (PECAM-1) in sera and hemovac drainage were measured by ELISA before and 24 hours after the surgery. We showed that patients receiving computer navigation TKAs had less blood loss and lower CAMs in serum and hemovac drainage after the operation. Less postoperative elevation of serum ICAM-1 (p=0.022) and PECAM-1 (p=0.003) from the preoperative baseline after the surgery was also noted. This study provides molecular evidence for the differential extent in vascular injury between conventional and navigation TKAs and sheds light on the possible benefits of computer navigation TKAs. TRIAL REGISTRATION: ClinicalTrials.gov NCT02206321.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25955252 PMCID: PMC4425488 DOI: 10.1371/journal.pone.0126663
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Flowchart of the participants through each stage of the study.
Baseline clinical and radiographic characteristics of patients undergoing conventional or navigation TKA surgery.
| Conventional | Navigation | P value | |
|---|---|---|---|
| Gender (Male/Female) | 10/23 | 14/40 | 0.66 |
| Side (L/R) | 17/16 | 28/26 | 0.98 |
| Age (years) | 71.0 (67.0, 78.0) | 71.0 (66.0, 74.0) | 0.35 |
| BMI | 26.2 (24.6, 29.8) | 28.6 (25.7, 30.2) | 0.16 |
| CHD / equivalent | 11/22 | 16/38 | 0.72 |
Serum concentrations of ICAM-1(unit: ng/mL) in patients before and after navigation and conventional TKAs, and the changes from preoperative baseline after surgery (post-OP—pre-OP).
| ICAM-1 | Before operation | After operation | Changes |
|---|---|---|---|
| Navigation | 155.3 (140.7, 170.4) | 158.1 (138.9,183.8) | -1.0 (-5.8, 11.5) |
| Conventional | 168.9 (132.6, 196.4) | 245.9 (206.7,274.6) | 1.0 (-1.3, 19.4) |
| p-value | 0.28 | < 0.001 | 0.022 |
Serum concentrations of VCAM-1 (unit:ng/mL) in patients before and after navigation and conventional TKAs, and the changes from preoperative baseline after surgery (post-OP—pre-OP).
| VCAM-1 | Before operation | After operation | Changes |
|---|---|---|---|
| Navigation | 489.2(466.1,517.4) | 580.0 (566.3,590.5) | 105.1 (81.2, 118.9) |
| Conventional | 495.6(449.9,557.6) | 592.6 (532.3,642.2) | 103.1 (85.5, 122.3) |
| p-value | 0.656 | 0.037 | 0.435 |
Serum concentrations of PECAM-1 (unit: pg/mL) in patients before and after navigation and conventional TKAs, and the changes from preoperative baseline after surgery (post-OP—pre-OP).
| PECAM-1 | Before operation | After operation | Changes |
|---|---|---|---|
| Navigation | 1071.1(570.6,1853.4) | 2243.4 (717.8,3716.6) | 1121.1 (212.2, 3213.1) |
| Conventional | 1498.9(636.9,4378.9) | 4429.4 (3460.0,6286.7) | 2899.1 (1901,7, 3558.3) |
| p-value | 0.152 | <0.001 | 0.003 |
Correlation of ICAM-1 concentrations (unit: ng/mL) in hemovac samples and postoperative serum samples.
| ICAM-1 | Hemovac | Post-OP serum | Correlation coefficient |
|---|---|---|---|
| Navigation | 123.1 (103.9,151.9) | 158.1 (138.9,183.8) | 0.62 (p<0.001) |
| Conventional | 148.0 (120.2,167.8) | 245.9 (206.7,274.6) | 0.54 (p = 0.007) |
| p-value | 0.005 | <0.001 |
Correlation of VCAM-1 concentrations (unit: ng/mL) in hemovac samples and postoperative serum samples.
| VCAM-1 | Hemovac | Post-OP serum | Correlation coefficient |
|---|---|---|---|
| Navigation | 437.4 (356.8,534.2) | 580.0 (566.3,590.5) | 0.61 (p<0.001) |
| Conventional | 481.2 (348.1,616.2) | 592.6 (532.3,642.2) | 0.70 (p<0.001) |
| p-value | 0.280 | 0.037 |
Correlation of PECAM-1 concentrations (unit: ng/mL) in hemovac samples and postoperative serum samples.
| PECAM-1 | Hemovac | Post-OP serum | Correlation coefficient |
|---|---|---|---|
| Navigation | 9004.2 (7009.7,12542.3) | 2243.4 (717.8,3716.6) | 0.15 (p = 0.384) |
| Conventional | 10225.6 (7539.7,12139.3) | 4429.4 (3460.0,6286.7) | 0.08 (p = 0.692) |
| p-value | 0.300 | <0.001 |